Can the halp score, a new prognostic tool, predict the progression of pseudoexfoliation patients to pseudoexfoliation glaucoma?

dc.contributor.authorAkbulut Yağcı, Betül
dc.contributor.authorErdal, Hüseyin
dc.date.accessioned2025-07-24T11:15:12Z
dc.date.available2025-07-24T11:15:12Z
dc.date.issued2025
dc.departmentTıp Fakültesi
dc.description.abstractThe present study aims to investigate the prognostic role of hemoglobin, albumin, lymphocyte, and platelet (HALP) score in pseudoexfoliation syndrome (PEXS) patients and its relationship with pseudoexfoliation glaucoma (PEXG) progression. Material and Methods: This retrospective study included 58 PEXS and 61 PEXG patients. All groups ' demographic information and hemograms, s were collected from the hospital automation system. The neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), systemic immuno-inflammatory index (SII), systemic inflammatory response index (SIRI), pan-immune inflammation value (PIV), and HALP were calculated to both groups. The results were compared among the groups. Results: In this study, there were 119 participants in total: 58 patients with PEXS with an average age of 71.3 +/- 8.9 years and 61 patients with PEXG with an average age of 71.3 +/- 8.9 years (p=0.15). In paired comparisons, it was observed that the NLR, PLR, SII, SIRI, and PIV indices of the groups were not found to be statistically significant (p>0.001). The HALP score value was lower in the PEXG group than the PEXS (4.73 +/- 1.99 and 6.3 +/- 2.63, respectively) (p<0.001). The AUC of the HALP score for PEXS and PEXG was 0.696. The optimal cut-off value of HALP to predict PEXG was <= 4.23, with 85% sensitivity and 51.7% specificity (95% confidence interval 0,605-0,777, p<0.01). Discussion: It was found that a lower HALP score was significantly associated with PEXG patients and could be an independent prognostic factor. Although this score alone is not sufficient, this study is important in that it may predict the possibility of developing PEXG.
dc.identifier.doi10.4328/ACAM.22378
dc.identifier.endpage275
dc.identifier.issn2667-663X
dc.identifier.issue4
dc.identifier.startpage272
dc.identifier.urihttps://dx.doi.org/10.4328/ACAM.22378
dc.identifier.urihttps://hdl.handle.net/20.500.12451/13567
dc.identifier.volume16
dc.identifier.wosWOS:001462328500008
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.institutionauthorAkbulut Yağcı, Betül
dc.institutionauthorErdal, Hüseyin
dc.publisherBayrakol MP
dc.relation.ispartofAnnals of Clinical and Analytical Medicine
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectHalp Score
dc.subjectPseudoexfoliation Glaucoma
dc.subjectPseudoexfoliation Syndrome
dc.titleCan the halp score, a new prognostic tool, predict the progression of pseudoexfoliation patients to pseudoexfoliation glaucoma?
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
akbulut yagci-betul-2025.pdf
Boyut:
261.86 KB
Biçim:
Adobe Portable Document Format
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: